NYR
Click for more information
1.79% 5.7¢ nyrada inc.

PCSK9 Patent

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    clock Created with Sketch.
    28/05/21
    13:32
    Post #: 53488796
    Not sure if this has already been reported ...

    Cardio Therapeutics received Notice of Allowance for their patent application Heterocyclic Inhibitors of PCSK9 on 6 April 2021. Patent grant will follow once formalities are completed.
    NYR Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.7¢ 		Change
0.001(1.79%) 		Mkt cap ! $10.38M
Open High Low Value Volume
5.6¢ 5.8¢ 5.5¢ $23.44K 412.2K

Buyers (Bids)

No. Vol. Price($)
2 171592 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 8000 1
View Market Depth
Last trade - 13.08pm 27/06/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.